M, P., A, S., B, S., F, D., M, P., L, O., . . . E, C. (2026). Targeting frataxin deficiency in DRG neurons and fibroblasts: Omaveloxolone restores metabolic and iron balance to reduce ferroptosis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 195, 119031. https://doi.org/10.1016/j.biopha.2026.119031
Chicago Style (17th ed.) CitationM, Portillo-Carrasquer, et al. "Targeting Frataxin Deficiency in DRG Neurons and Fibroblasts: Omaveloxolone Restores Metabolic and Iron Balance to Reduce Ferroptosis." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 195 (2026): 119031. https://doi.org/10.1016/j.biopha.2026.119031.
MLA (9th ed.) CitationM, Portillo-Carrasquer, et al. "Targeting Frataxin Deficiency in DRG Neurons and Fibroblasts: Omaveloxolone Restores Metabolic and Iron Balance to Reduce Ferroptosis." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 195, 2026, p. 119031, https://doi.org/10.1016/j.biopha.2026.119031.